Shareholders Approve Reverse Stock Split to Address Nasdaq Listing Requirements

summarizeSummary

Cardlytics shareholders approved a reverse stock split, giving the Board discretion to execute it to help the company meet Nasdaq's minimum bid price requirement.

check_boxKey Events

• Reverse Stock Split Approved

  Stockholders approved a proposal allowing the Board to effect a reverse stock split at a ratio between 1-for-5 and 1-for-15, along with a proportionate reduction in authorized shares. This addresses the company's need to meet Nasdaq's minimum bid price requirement, following a DEF 14A filing on 2026-04-09 seeking this approval.

• Directors Re-elected

  Three nominees (Amit Gupta, Jack Klinck, and Shrishti Gupta) were elected to serve as Class II directors until the 2029 annual meeting.

• Auditor Ratified

  The selection of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026 was ratified by stockholders.

• Executive Compensation Approved

  Stockholders approved, on an advisory basis, the compensation of the company's named executive officers.

auto_awesomeAnalysis

Cardlytics shareholders have approved a proposal granting the Board the option to implement a reverse stock split at a ratio between 1-for-5 and 1-for-15. This is a critical step for the company, which is currently trading below $1.00, to meet Nasdaq's minimum bid price requirement and avoid potential delisting. The approval provides the company with the necessary flexibility to maintain its exchange listing.